| Geneviève Lemaire |
Ms. Geneviève Lemaire, CPA, is Chief Accounting Officer & Vice President-Finance at Æterna Zentaris, Inc. He received his undergraduate degree from the University of Sherbrooke. |
| Michael Teifel |
Michael Teifel is the founder of Munich Biotech AG, which was founded in 1998. He held the title of Head-Pharmacology & Toxicology from 1998 to 2004. Currently, Dr. Teifel is the Chief Scientific Officer & Senior Vice President at Æterna Zentaris, Inc. since 2004. He is also the Head-Translational Sciences at Cleara Biotech BV. Previously, Dr. Teifel worked at AEterna Zentaris GmbH from 2004 to 2019, where he held the title of Vice President-Non Clinical Services from 2014 to 2019. Dr. Teifel obtained his doctorate degree from Technische Universität Darmstadt in 1996. |
| Nicola Ammer |
Nicola Ammer currently works at Æterna Zentaris, Inc., as Chief Medical Officer & Senior Vice President from 2014 and AEterna Zentaris GmbH, as Head-Clinical Development. Dr. Ammer also formerly worked at Pierrel Research International AG, as Head-European Business Development Operations from 2011 to 2013. Dr. Ammer received her graduate degree in 2009 from the University of Duisburg-Essen. |
| Carolyn Egbert |
Carolyn Egbert is currently the Non-Executive Chairman at Æterna Zentaris, Inc. She is also a Member of The District of Columbia Bar and the State Bar of Michigan. Previously, she held the position of Senior Executive VP-Global Ethics & Compliance at Solvay America, Inc. Dr. Egbert has an undergraduate degree from George Washington University, a graduate degree from Seattle University, and doctorate degrees from Georgetown University School of Medicine and Feinberg School of Medicine. |
| Giuliano La Fratta |
Giuliano La Fratta is currently the Chief Financial Officer & Senior Vice President at Æterna Zentaris, Inc. Prior to this, he was the Vice President-Finance at CellCarta Biosciences, Inc. He obtained his undergraduate degree from Concordia University. |
| Klaus Wolfgang Paulini |
Klaus Wolfgang Paulini is currently the President, Chief Executive Officer & Director at Æterna Zentaris, Inc. He is also the Co-Managing Director at AEterna Zentaris GmbH and Zentaris IVF GmbH. Dr. Paulini obtained his doctorate degree from Technische Universität Darmstadt in 1993. |
| Gilles R. Gagnon |
Gilles R. Gagnon is the founder of Prodev Pharma, Inc. (founded in 2007) where he holds the title of President. He is currently the President, Chief Executive Officer & Director at Ceapro, Inc. (since 2012), a Member of the CEO Council at Innovative Medicines Canada, the Chairman at JuventeDC, Inc., an Independent Director at Æterna Zentaris, Inc. (since 2020), and a Member of the Institute of Corporate Directors. In his former positions, Mr. Gagnon served as the President & Chief Executive Officer of Æterna Zentaris, Inc. (1999-2007), Chairman of BioQuebec, an Independent Non-Executive Director at Spectrum Pharmaceuticals, Inc., and an Executive Director at Warnex, Inc. (2010). He also held the position of Director of Professional Services at Sandoz Pharmaceuticals Corp. (1989-1996), Director at Montreal Invivo Organization, and Director at Sherbrooke Innopole. Additionally, he served as the President of Spectrum Pharma Canada, Inc. (2008-2015) and Vice President of External Affairs at Novartis Pharma Canada, Inc. (1996-1999). Mr. Gagnon obtained a graduate degree and an MBA from the University of Sherbrooke. |
| Peter G. Edwards |
Peter G. Edwards is an Independent Director at Æterna Zentaris, Inc. He previously worked as an Attorney at Eli Lilly & Co., Secretary & General Counsel at Mettler-Toledo International, Inc., Senior Vice President & General Counsel at Mallinckrodt Plc, Executive Vice President & General Counsel at Celanese Corp., Baxalta, Inc., and Solvay Pharmaceuticals, Inc., and as an Associate at Shook, Hardy & Bacon LLP. He also served as Vice President & General Counsel at Covidien Unlimited Co. and as Executive Vice President & General Counsel at Solvay Pharmaceuticals SA. He was also the Secretary & General Counsel at Global Home Products LLC and General Counsel at Elutia, Inc. Edwards received his undergraduate degree from Brigham Young University in 1987 and his graduate degree from the same institution. |
